Skip to main content
Pharmafile

Is the Current EU Legal Framework for Orphan Medicines Fit for Purpose?

Autumn 2019
Authors
Maria Isabel ManleyDr. Chris Boyle

Maria Isabel Manley, partner and head of the UK Global Life Sciences Practice, and Chris Boyle, associate, at Sidley, discuss the impact of regulatory frameworks on medicines for rare diseases.

View Article

Contacts

Manley, Maria Isabel
合伙人律师
Boyle, Chris
合伙人律师

Capabilities

Suggested News & Insights

Sidley Recognized in Legal 500 EMEA 2026March 25, 2026
荣誉
Sidley Represents Salt & Stone in Majority Stake Acquisition by AdventMarch 24, 2026
公告
Sidley Represents Apollo Funds in Minority Investment in SyntegonMarch 23, 2026
公告
Sidley Ranked in Chambers Europe 2026March 19, 2026
荣誉
Sidley Advises Verdane in Its Partnership With SmartboxMarch 12, 2026
公告
New U.S. FDA Letter Contradicts Decades-Old Precedent on Prescription Drug PromotionMarch 10, 2026
Global Life Sciences Update